(a) Common significant GOs of T2D and AD |
GO ID
|
Pathway
|
p
-Value
|
GO:0032000 |
positive regulation of fatty acid beta-oxidation |
5.99
|
GO:0016064 |
immunoglobulin mediated immune response |
6.73
|
GO:2000269 |
regulation of fibroblast apoptotic process |
6.73
|
GO:0031998 |
regulation of fatty acid beta-oxidation |
8.22
|
GO:0051588 |
regulation of neurotransmitter transport |
1.05
|
GO:0007498 |
mesoderm development |
1.64
|
GO:0051961 |
negative regulation of nervous system development |
1.71
|
GO:0046928 |
regulation of neurotransmitter secretion |
2.08
|
(b) Common significant GOs of T2D and ALS |
GO ID
|
Pathway
|
p
-Value
|
GO:0006352 |
DNA-templated transcription, initiation |
2.46
|
GO:0050870 |
positive regulation of T cell activation |
4.48
|
GO:0048935 |
peripheral nervous system neuron development |
1.01
|
GO:0021522 |
spinal cord motor neuron differentiation |
1.01
|
GO:0021559 |
trigeminal nerve development |
1.01
|
GO:2000145 |
regulation of cell motility |
1.10
|
GO:0048665 |
neuron fate specification |
1.15
|
GO:1902692 |
regulation of neuroblast proliferation |
1.58
|
GO:0048663 |
neuron fate commitment |
2.01
|
GO:2000177 |
regulation of neural precursor cell proliferation |
2.15
|
GO:0014033 |
neural crest cell differentiation |
2.30
|
GO:0045597 |
positive regulation of cell differentiation |
3.23
|
GO:0051961 |
negative regulation of nervous system development |
3.28
|
GO:0019228 |
neuronal action potential |
3.42
|
GO:0021953 |
central nervous system neuron differentiation |
4.68
|
GO:0050768 |
negative regulation of neurogenesis |
4.82
|
(c) Common significant GOs of T2D and CP |
GO ID
|
Pathway
|
p
-Value
|
GO:0071363 |
cellular response to growth factor stimulus |
5.47
|
GO:0048681 |
negative regulation of axon regeneration |
6.38
|
GO:0070571 |
negative regulation of neuron projection regeneration |
7.18
|
GO:0099590 |
neurotransmitter receptor internalization |
8.77
|
GO:0048679 |
regulation of axon regeneration |
8.77
|
GO:0021952 |
central nervous system projection neuron axonogenesis |
8.77
|
GO:0008045 |
motor neuron axon guidance |
8.77
|
GO:0106030 |
neuron projection fasciculation |
8.77
|
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway |
1.67
|
GO:0071875 |
adrenergic receptor signaling pathway |
1.67
|
GO:1990090 |
cellular response to nerve growth factor stimulus |
1.82
|
GO:0010977 |
negative regulation of neuron projection development |
4.08
|
GO:0016192 |
vesicle-mediated transport |
4.18
|
GO:0001934 |
positive regulation of protein phosphorylation |
4.22
|
(d) Common significant GOs of T2D and ED |
GO ID
|
Pathway
|
p
-Value
|
GO:0006897 |
endocytosis |
6.45
|
GO:0007599 |
hemostasis |
1.15
|
GO:0090286 |
cytoskeletal anchoring at the nuclear membrane |
1.30
|
GO:0034214 |
protein hexamerization |
1.44
|
GO:0034063 |
stress granule assembly |
1.73
|
GO:0097205 |
renal filtration |
1.73
|
GO:0035278 |
miRNA mediated inhibition of translation |
1.73
|
GO:0071470 |
cellular response to osmotic stress |
2.15
|
GO:0034656 |
nucleobase-containing small molecule catabolic process |
2.30
|
GO:0021953 |
central nervous system neuron differentiation |
4.68
|
(e) Common significant GOs of T2D and HD |
GO ID
|
Pathway
|
p
-Value
|
GO:0042127 |
regulation of cell proliferation |
6.92
|
GO:0022409 |
positive regulation of cell-cell adhesion |
2.16
|
GO:0048665 |
neuron fate specification |
5.19
|
GO:0048663 |
neuron fate commitment |
9.06
|
GO:0014033 |
neural crest cell differentiation |
1.04
|
GO:0043161 |
proteasome-mediated ubiquitin-dependent protein catabolic process |
1.49
|
GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway |
2.65
|
GO:0007399 |
nervous system development |
3.43
|
(f) Common significant GOs of T2D and MS |
GO ID
|
Pathway
|
p
-Value
|
GO:0070229 |
negative regulation of lymphocyte apoptotic process |
4.32
|
GO:0099590 |
neurotransmitter receptor internalization |
5.27
|
GO:0051588 |
regulation of neurotransmitter transport |
8.67
|
GO:0050804 |
modulation of chemical synaptic transmission |
2.29
|
GO:0046928 |
regulation of neurotransmitter secretion |
3.50
|
GO:2000146 |
negative regulation of cell motility |
3.66
|
GO:0090181 |
regulation of cholesterol metabolic process |
7.75
|
GO:0072657 |
protein localization to membrane |
1.43
|
GO:0007005 |
mitochondrion organization |
1.60
|
GO:0010595 |
positive regulation of endothelial cell migration |
2.11
|
GO:0010646 |
regulation of cell communication |
2.17
|
GO:0050658 |
RNA transport |
2.70
|
GO:0010628 |
positive regulation of gene expression |
3.43
|
GO:2000145 |
regulation of cell motility |
4.71
|
GO:0014033 |
neural crest cell differentiation |
4.92
|
(g) Common significant GOs of T2D and PD |
GO ID
|
Pathway
|
p
-Value
|
GO:0070486 |
leukocyte aggregation |
9.16
|
GO:0070584 |
mitochondrion morphogenesis |
1.14
|
GO:0090128 |
regulation of synapse maturation |
1.26
|
GO:0045624 |
positive regulation of T-helper cell differentiation |
1.37
|
GO:0048854 |
brain morphogenesis |
1.37
|
GO:0019228 |
neuronal action potential |
2.73
|
GO:0097061 |
dendritic spine organization |
2.84
|
GO:0030199 |
collagen fibril organization |
3.40
|
GO:0061448 |
connective tissue development |
3.51
|
GO:0048813 |
dendrite morphogenesis |
3.73
|
GO:0099601 |
regulation of neurotransmitter receptor activity |
3.84
|